Chronicle Journal: Finance

Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Blueprint Medicines Corp (NQ: BPMC)
66.98 USD  +3.17 (+4.97%)
Official Closing Price  /  Updated: 4:48 PM EST, Feb 14, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 568,700
Open 63.47
Bid (Size) 66.00 (2)
Ask (Size) 70.00 (5)
Prev. Close 63.81
Today's Range 63.20 - 67.24
52wk Range 60.60 - 102.98
Shares Outstanding 43,837,337
Dividend Yield N/A
Performance
YTD
-18.51%
-18.51%
1 Month
-17.27%
-17.27%
3 Month
-10.14%
-10.14%
6 Month
-17.58%
-17.58%
1 Year
-11.97%
-11.97%
Top News
More News
Blueprint Medicines Reports Fourth Quarter and Full Year 2019 Financial Results
- Obtained FDA approval and launched AYVAKIT™ (avapritinib), the first approved precision therapy for GIST and only highly active treatment for PDGFRA exon 18 mutant GIST - Read More
from PR Newswire
Blueprint Medicines to Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, February 13, 2020
Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that it will host a live... Read More
from PR Newswire
More News
Read More
Blueprint Medicines Announces PDUFA Date Extension for New Drug Application of Avapritinib for the Treatment of Adults with Fourth-Line Gastrointestinal Stromal Tumor
from PR Newswire
About to Buy Penny Stocks? Look at These 2 Companies First
category DTIL , BPMC , PFE , and 2 more.
from Motley Fool
Blueprint Medicines (BPMC) Q4 2019 Earnings Call Transcript
category BPMC , Market News
from Motley Fool
Notable Thursday Option Activity: BPMC, CACC, BYND
category Stocks
from Market News Video
Investors Snag BPMC 5.6% Cheaper Than Its Secondary Stock Offering
category Stocks
from Market News Video
Blueprint Medicines Enters Oversold Territory (BPMC)
category Stocks
from Market News Video
UPDATE 1-FDA approves Epizyme's treatment for rare tissue cancer
category companyNews
from Reuters: Company News
Interesting BPMC Put And Call Options For May 15th
category Stocks
from Market News Video
The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO
category ITMR , Pre/Market Outlook , APVO , and 80 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]